Earnings History Data for Tempest Therapeutics (TPST) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Tempest Therapeutics

Tempest Therapeutics Inc. is a clinical-stage oncology company developing potentially first-in-class therapeutics which combines both targeted and immune-mediated mechanisms. Tempest Therapeutics Inc., formerly known as Millendo Therapeutics Inc., is based in Calif.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
19-03-2024 AH TPST Tempest Therapeutics 70.00 -0.34 -0.38 0.00 Tempest Therapeutics GAAP EPS of -$1.91 beats by $0.03
[3/19/2024 4:37 PM]
3.73 -0.01 
(-0.27%)
3.80 0.06 
(1.60%)
0.17 - 9.77 760,880 680,000 39,012
08-11-2023 AH TPST Tempest Therapeutics 41.00 -0.48 -0.55 0.00 Tempest Therapeutics GAAP EPS of -$0.48 beats by $0.09
[11/8/2023 6:04 PM]
3.28 0.46 
(16.31%)
3.46 0.64 
(22.70%)
0.17 - 9.77 54,707,073 2,720,000 1,196,417
10-08-2023 PM TPST Tempest Therapeutics 7.00 -0.54 -0.58 0.00 Tempest Therapeutics GAAP EPS of -$0.54 misses by $0.06
[8/11/2023 4:27 AM]
0.62 0.01 
(1.64%)
0.62 0.01 
(1.64%)
0.54 - 4.21 195,323 220,000 13,789
10-05-2023 AH After the close
(May 10)
TPST Tempest Therapeutics 22.00 -0.55 -0.66 0.00 Tempest Therapeutics GAAP EPS of -$0.55 beats by $0.07
[5/10/2023 5:28 PM]
2.13 0.07 
(3.40%)
1.98 -0.08 
(-3.88%)
1.06 - 4.21 53,399 1,310,000 1,452
22-03-2023 AH TPST Tempest Therapeutics 13.00 -0.63 -0.72 0.00 Tempest Therapeutics GAAP EPS of -$3.09 beats by $0.43
[3/22/2023 5:32 PM]
1.40 0.09 
(6.52%)
1.43 0.12 
(8.80%)
1.06 - 4.55 11,696 10,000 949
15-08-2022 PM TPST Tempest Therapeutics 24.00 -0.79 -0.92 0.00 Tempest Therapeutics GAAP EPS of -$0.79
[8/15/2022 8:32 AM]
2.46 0.32 
(14.65%)
2.18 0.03 
(1.40%)
2.00 - 16.39 71,168 20,000 561
13-05-2022 PM TPST Tempest Therapeutics 20.00 -1.18 -1.12 0.00 Tempest Therapeutics GAAP EPS of -$1.18 misses by $0.06
[5/13/2022 8:35 AM]
2.89 0.17 
(6.25%)
0.0 0.0 
(0.00%)
2.16 - 41.00 114,155 300,000 0
29-03-2022 AH 4:05 PM ET
(Mar 29)
TPST Tempest Therapeutics, Inc. 27.23 N/A -1.22 0.00 Tempest Therapeutics GAAP EPS of -$7.47
[3/29/2022 4:51 PM]
3.50 -0.30 
(-7.89%)
3.96 0.16 
(4.21%)
2.16 - 41.00 6,972 40,000 300
10-11-2021 AH TPST Tempest Therapeutics 80.00 -1.21 -1.05 0.00 Tempest Therapeutics reports Q3 results
[11/10/2021 4:48 PM]
11.78 0.12 
(1.03%)
0.0 0.0 
(0.00%)
10.38 - 41.55 7,574 10,000 0
12-08-2021 AH TPST Tempest Therapeutics, Inc. 17.00 -7.63 -0.88 0.00 Tempest Therapeutics reports Q2 results
[8/12/2021 5:08 PM]
13.19 -0.54 
(-3.93%)
13.45 -0.28 
(-2.04%)
10.38 - 41.55 103,677 250,000 130